Polymer Capital Management (Us) LLC Intellia Therapeutics, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 15,230 shares of NTLA stock, worth $122,906. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,230Holding current value
$122,906% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.3MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$105 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$86.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$77.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$36.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$30.7 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $613M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...